‌

Updated Interim Clinical Considerations for use of COVID-19 Vaccine

County of Los Angeles, California sent this bulletin at 04/25/2023 12:00 PM PDT

CDC has updated the Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States to reflect the following changes in the mRNA COVID-19 vaccination schedule:

At the time of initial vaccination, depending on vaccine product, children ages 6 months–4 years are recommended to receive 2 or 3 bivalent mRNA vaccine doses; children age 5 years are recommended to receive 1 or 2 bivalent mRNA vaccine doses.
People ages 6 years and older who are unvaccinated or previously received only monovalent vaccine doses are recommended to receive 1 bivalent mRNA vaccine dose.
People ages 65 years and older may receive 1 additional bivalent mRNA vaccine dose.

We will share updated clinical guidance for individuals who are immunocompromised as soon as possible.

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com.

This service is provided to you at no charge by County of Los Angeles.